| Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin S Dalva-Aydemir, R Bajpai, M Martinez, KUA Adekola, I Kandela, C Wei, ... Clinical Cancer Research 21 (5), 1161-1171, 2015 | 145 | 2015 |
| Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax R Bajpai, SM Matulis, C Wei, AK Nooka, HE Von Hollen, S Lonial, ... Oncogene 35 (30), 3955-3964, 2016 | 98 | 2016 |
| Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion R Commander, C Wei, A Sharma, JK Mouw, LJ Burton, E Summerbell, ... Nature communications 11 (1), 1533, 2020 | 78 | 2020 |
| Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma R Bajpai, A Sharma, A Achreja, CL Edgar, C Wei, AA Siddiqa, VA Gupta, ... Nature communications 11 (1), 1228, 2020 | 73 | 2020 |
| In silico modeling-based identification of glucose transporter 4 (GLUT4)-selective inhibitors for cancer therapy RK Mishra, C Wei, RC Hresko, R Bajpai, M Heitmeier, SM Matulis, ... Journal of Biological Chemistry 290 (23), 14441-14453, 2015 | 72 | 2015 |
| RRM2 is a potential prognostic biomarker with functional significance in glioma H Sun, B Yang, H Zhang, J Song, Y Zhang, J Xing, Z Yang, C Wei, T Xu, ... International journal of biological sciences 15 (3), 533, 2019 | 58 | 2019 |
| Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway FI Lu, YH Sun, CY Wei, C Thisse, B Thisse Nature communications 5 (1), 5368, 2014 | 56 | 2014 |
| Development of GLUT4-selective antagonists for multiple myeloma therapy C Wei, R Bajpai, H Sharma, M Heitmeier, AD Jain, SM Matulis, AK Nooka, ... European journal of medicinal chemistry 139, 573-586, 2017 | 49 | 2017 |
| PSMB8 regulates glioma cell migration, proliferation, and apoptosis through modulating ERK1/2 and PI3K/AKT signaling pathways B Yang, J Song, H Sun, J Xing, Z Yang, C Wei, T Xu, Z Yu, Y Zhang, ... Biomedicine & Pharmacotherapy 100, 205-212, 2018 | 48 | 2018 |
| Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5 CY Wei, HP Wang, ZY Zhu, YH Sun Journal of Biological Chemistry 289 (10), 6604-6618, 2014 | 36 | 2014 |
| Marcksb plays a key role in the secretory pathway of zebrafish Bmp2b D Ye, X Wang, C Wei, M He, H Wang, Y Wang, Z Zhu, Y Sun PLoS genetics 15 (9), e1008306, 2019 | 22 | 2019 |
| Correlation between adiponectin gene rs1501299 polymorphism and nonalcoholic fatty liver disease susceptibility: a systematic review and meta-analysis J Liu, J Xing, B Wang, C Wei, R Yang, Y Zhu, H Qiu Medical science monitor: international medical journal of experimental and …, 2019 | 20 | 2019 |
| Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor L Huang, R Bommireddy, LE Munoz, RN Guin, C Wei, A Ruggieri, ... PLoS One 16 (8), e0254125, 2021 | 16 | 2021 |
| Evaluating the efficacy of GLUT inhibitors using a seahorse extracellular flux analyzer C Wei, M Heitmeier, PW Hruz, M Shanmugam Glucose Transport: Methods and Protocols, 69-75, 2018 | 13 | 2018 |
| Subtractive phage display technology identifies zebrafish marcksb that is required for gastrulation YW Wang, CY Wei, HP Dai, ZY Zhu, YH Sun Gene 521 (1), 69-77, 2013 | 5 | 2013 |
| Correction: Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5 CY Wei, HP Wang, ZY Zhu, YH Sun Journal of Biological Chemistry 296, 2021 | 2 | 2021 |
| GLUT4 exhibits a non-canonical role of regulating lung cancer metastasis C Wei, A Achreja, J Konen, G Sica, M Gilbert-Ross, D Nagrath, A Marcus, ... Cancer Research 77 (13_Supplement), 4904-4904, 2017 | 2 | 2017 |
| Transcriptional factors Smad1 and Smad9 act redundantly to mediate zebrafish ventral specification downstream of Smad5 (vol 289, pg 6604, 2014) CY Wei, HP Wang, ZY Zhu, YH Sun JOURNAL OF BIOLOGICAL CHEMISTRY 295 (52), 18650-18650, 2020 | | 2020 |
| Deciphering a metabolic basis for single-agent venetoclax efficacy in t (11; 14) multiple myeloma R Bajpai, A Achreja, C Wei, A Siddiqa, SM Matulis, V Gupta, SK McBrayer, ... Cancer Research 79 (13_Supplement), 2715-2715, 2019 | | 2019 |
| Succinate Ubiquinone Reductase Activity Predicts Multiple Myeloma Sensitivity to Venetoclax R Bajpai, C Wei, S Matulis, AK Nooka, S McBrayer, S Lonial, VA Gupta, ... Blood 130, 4409, 2017 | | 2017 |
Richa BajpaiScientistVerified email at stjude.org
